人民财讯3月25日电,药明生物在港交所公告,2024年收益同比增长9.6%,达人民币186.75亿元。毛利同比增长12.1%至人民币76.51亿元,纯利同比增长10.5%至人民币39.45亿元。
(文章来源:人民财讯)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.